Clustering of KOR PET images separates people with AUD into distinct responses to naltrexone

Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al.  Biological Psychiatry , 86 (11), 864-871, 2019 ). The purpose of the current study...

Full description

Saved in:
Bibliographic Details
Published inBrain imaging and behavior Vol. 17; no. 3; pp. 367 - 371
Main Authors Hoye, Jocelyn, Key, Jose, de Laat, Bart, Cosgrove, Kelly P., Krishnan-Sarin, Suchitra, Papademetris, Xenophon, Morris, Evan D.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.06.2023
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al.  Biological Psychiatry , 86 (11), 864-871, 2019 ). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, V T ) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry , 62 (6), 694-697, 2007 ) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects’ responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone.
AbstractList Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry, 86(11), 864-871, 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, VT) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry, 62(6), 694-697, 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects’ responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone.
Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, V T ) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects’ responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone.
Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al.  Biological Psychiatry , 86 (11), 864-871, 2019 ). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, V T ) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry , 62 (6), 694-697, 2007 ) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects’ responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone.
Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry, 86(11), 864-871, 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, V ) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry, 62(6), 694-697, 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects' responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone.
Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry, 86(11), 864-871, 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, VT) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry, 62(6), 694-697, 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects' responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone.Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking following a week of naltrexone treatment (de Laat et al. Biological Psychiatry, 86(11), 864-871, 2019). The purpose of the current study was to determine if spectral clustering applied to previously acquired KOR images (with [11C]LY2795050 PET) could identify meaningful groupings of different responses to naltrexone and to assess the robustness of the finding. Spectral clustering was applied to 6 features (regional volume of distribution values, VT) per AUD subject to produce 3 classes of subjects with different mean responses to naltrexone. Response to naltrexone was quantified as the difference in drinks consumed in an established lab-based alcohol drinking paradigm (Krishnan-Sarin et al. Biological Psychiatry, 62(6), 694-697, 2007) prior to, and after a week of naltrexone treatment. Clustering was applied exclusively to features of the image data with no a priori knowledge of the subjects' responses. Separation of classes was tested using a 1-way analysis of variance (ANOVA) with drink reduction as the outcome of interest. To assess robustness of the result, the size of the training set was varied by using successively reduced subsets of the data. Clustering resulted in significantly different groupings of drink reduction. The finding was robust to initialization of the spectral clustering procedure and was replicable for different random subsets of training subjects. Finding: Spectral clustering of kappa PET images separates AUD subjects into behaviorally distinct groups expressing distinct responses to naltrexone.
Author Hoye, Jocelyn
Papademetris, Xenophon
Krishnan-Sarin, Suchitra
Morris, Evan D.
Key, Jose
Cosgrove, Kelly P.
de Laat, Bart
AuthorAffiliation 3 Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA
1 Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, New Haven, CT, USA
2 Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
4 Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA
AuthorAffiliation_xml – name: 1 Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, New Haven, CT, USA
– name: 3 Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA
– name: 4 Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA
– name: 2 Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
Author_xml – sequence: 1
  givenname: Jocelyn
  surname: Hoye
  fullname: Hoye, Jocelyn
  email: Jocelyn.hoye@yale.edu
  organization: Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, Department of Radiology and Biomedical Imaging, Yale School of Medicine
– sequence: 2
  givenname: Jose
  surname: Key
  fullname: Key, Jose
  organization: Department of Biomedical Engineering, Yale School of Medicine
– sequence: 3
  givenname: Bart
  surname: de Laat
  fullname: de Laat, Bart
  organization: Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, Department of Radiology and Biomedical Imaging, Yale School of Medicine
– sequence: 4
  givenname: Kelly P.
  surname: Cosgrove
  fullname: Cosgrove, Kelly P.
  organization: Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, Department of Radiology and Biomedical Imaging, Yale School of Medicine, Department of Psychiatry, Yale School of Medicine
– sequence: 5
  givenname: Suchitra
  surname: Krishnan-Sarin
  fullname: Krishnan-Sarin, Suchitra
  organization: Department of Psychiatry, Yale School of Medicine
– sequence: 6
  givenname: Xenophon
  surname: Papademetris
  fullname: Papademetris, Xenophon
  organization: Department of Radiology and Biomedical Imaging, Yale School of Medicine, Department of Biomedical Engineering, Yale School of Medicine
– sequence: 7
  givenname: Evan D.
  surname: Morris
  fullname: Morris, Evan D.
  organization: Yale Positron Emission Tomography (PET) Center, Yale School of Medicine, Department of Radiology and Biomedical Imaging, Yale School of Medicine, Department of Biomedical Engineering, Yale School of Medicine, Department of Psychiatry, Yale School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36695971$$D View this record in MEDLINE/PubMed
BookMark eNp9kUlvFDEQhS0URBb4AxyQJS5cGmx3ezuhaAiLiBSEkhuS5XFXTxz12I3tZvn3uJkwQA45efvq-VW9Y3QQYgCEnlLykhIiX2VKhWINYW1Tj1w14gE6orqljeSCH-z3XB6i45xvCOGd0vQROmyF0FxLeoS-rMY5F0g-bHAc8MeLz_jT2SX2W7uBjDNMNtlSdxPEaQT83ZdrfHr1BvtQIu59Lj64ghPkKYZcuXob7FgS_KheH6OHgx0zPLldT9DV27PL1fvm_OLdh9XpeeM6yUvTEaE1dxKkk1qxnmktujWzg2XOcTpoNhBHnOqJ0452fcvVGrRYO6tJNwBrT9Drne40r7fQOwgl2dFMqbaRfppovfn_Jfhrs4nfDKWK1jnIqvDiViHFrzPkYrY-OxhHGyDO2TC5DIzyTlT0-R30Js6pNl2pqkYkVVJV6tm_lvZe_ky-AmwHuBRzTjDsEUrMEq_ZxWtqvOZ3vGb5W90pcr7Y4uPSlh_vL213pXlawob01_Y9Vb8Aa5655g
CitedBy_id crossref_primary_10_1021_acs_jmedchem_2c01965
crossref_primary_10_1016_j_peptides_2024_171268
Cites_doi 10.1016/j.neuroimage.2009.12.119
10.1007/s002130100919
10.2967/jnumed.112.118877
10.1111/acer.13406
10.1097/01.WCB.0000038000.34930.4E
10.1016/j.biopsych.2019.05.021
10.1016/j.biopsych.2006.11.018
10.1038/s41386-018-0199-1
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TK
7X7
7XB
88E
88G
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
LK8
M0S
M1P
M2M
M7P
NAPCQ
P5Z
P62
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1007/s11682-023-00758-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Biological Science Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Advanced Technologies & Aerospace Database
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology


MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1931-7565
EndPage 371
ExternalDocumentID PMC11815977
36695971
10_1007_s11682_023_00758_6
Genre Journal Article
GrantInformation_xml – fundername: NCATS NIH HHS
  grantid: UL1 TR000142
– fundername: NIAAA NIH HHS
  grantid: R01 AA021818
– fundername: NIAAA NIH HHS
  grantid: P50 AA012870
GroupedDBID ---
-55
-5G
-BR
-EM
-Y2
-~C
.86
.VR
04C
06D
0R~
0VY
1N0
203
23N
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5GY
5VS
67Z
6J9
6NX
7RV
7X7
875
88E
8FE
8FG
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIVO
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARAPS
ARMRJ
AXYYD
AZQEC
B-.
BA0
BBNVY
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIHBH
EIOEI
EJD
EMOBN
ESBYG
EX3
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HLICF
HMCUK
HMJXF
HQYDN
HRMNR
HZ~
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
LK8
LLZTM
M1P
M2M
M4Y
M7P
MA-
NAPCQ
NPVJJ
NQJWS
NU0
O9-
O93
O9J
OAM
P62
P9L
PF0
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
QOR
QOS
R89
R9I
ROL
RPX
RSV
S16
S1Z
S27
S3B
SAP
SBS
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WK8
WOW
YLTOR
Z45
Z82
Z83
ZMTXR
ZOVNA
~A9
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7XB
8FK
ABRTQ
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c475t-406995c7e7c7982d29964b2afa2cc51f92f0c0c8d0c9c14d358be96bca904fe23
IEDL.DBID 7X7
ISSN 1931-7557
1931-7565
IngestDate Thu Aug 21 18:29:00 EDT 2025
Thu Jul 10 17:33:21 EDT 2025
Fri Jul 25 10:39:50 EDT 2025
Thu Apr 03 07:05:13 EDT 2025
Thu Apr 24 22:58:47 EDT 2025
Tue Jul 01 04:04:35 EDT 2025
Fri Feb 21 02:44:43 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Spectral clustering
Alcohol use disorder
Positron emission tomography
Small sample size
Machine learning
Kappa opioid receptor
Language English
License 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c475t-406995c7e7c7982d29964b2afa2cc51f92f0c0c8d0c9c14d358be96bca904fe23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
JH wrote code, analyzed data, prepared figure 1, and wrote the original draft of the manuscript. JK wrote code and analyzed data. BDL curated data, provided scientific interpretation, and edited the manuscript. KPC provided scientific interpretation and edited the manuscript. SK-S designed the ADP procedures, provided scientific interpretation, and edited the manuscript. XP designed the clustering procedures, provided clustering code, provided scientific interpretation, and edited the manuscript. EDM designed the study, designed the PET procedures, provided scientific interpretation, and edited the manuscript.
Author’s Contributions
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/11815977
PMID 36695971
PQID 2815071878
PQPubID 1486349
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11815977
proquest_miscellaneous_2769591546
proquest_journals_2815071878
pubmed_primary_36695971
crossref_primary_10_1007_s11682_023_00758_6
crossref_citationtrail_10_1007_s11682_023_00758_6
springer_journals_10_1007_s11682_023_00758_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-06-01
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-01
  day: 01
PublicationDecade 2020
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
– name: Indianapolis
PublicationTitle Brain imaging and behavior
PublicationTitleAbbrev Brain Imaging and Behavior
PublicationTitleAlternate Brain Imaging Behav
PublicationYear 2023
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Krishnan-Sarin, Krystal, Shi, Pittman, O’Malley (CR5) 2007; 62
Kim, Zheng, Nabulsi, Labaree, Ropchan, Najafzadeh, Carson, Huang, Morris (CR4) 2013; 54
de Laat, Goldberg, Shi, Tetrault, Nabulsi, Zheng, Najafzadeh, Gao, Kapinos, Ropchan, O'Malley, Huang, Morris, Krishnan-Sarin (CR2) 2019; 86
Ichise, Toyama, Innis, Carson (CR3) 2002; 22
O'Malley, Krishnan-Sarin, Farren, Sinha, Kreek (CR6) 2002; 160
CR8
Shen, Papademetris, Constable (CR7) 2010; 50
Anderson, Becker (CR1) 2017; 41
Vijay, Cavallo, Goldberg, de Laat, Nabulsi, Huang, Krishnan-Sarin, Morris (CR9) 2018; 43
SJ Kim (758_CR4) 2013; 54
B de Laat (758_CR2) 2019; 86
S Krishnan-Sarin (758_CR5) 2007; 62
M Ichise (758_CR3) 2002; 22
758_CR8
A Vijay (758_CR9) 2018; 43
RI Anderson (758_CR1) 2017; 41
SS O'Malley (758_CR6) 2002; 160
X Shen (758_CR7) 2010; 50
References_xml – volume: 50
  start-page: 1027
  issue: 3
  year: 2010
  end-page: 1035
  ident: CR7
  article-title: Graph-theory based parcellation of functional subunits in the brain from resting-state fMRI data
  publication-title: Neuroimage.
  doi: 10.1016/j.neuroimage.2009.12.119
– volume: 160
  start-page: 19
  issue: 1
  year: 2002
  end-page: 29
  ident: CR6
  article-title: Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis
  publication-title: Psychopharmacology.
  doi: 10.1007/s002130100919
– volume: 54
  start-page: 1668
  issue: 9
  year: 2013
  end-page: 1674
  ident: CR4
  article-title: Determination of the in vivo selectivity of a new kappa-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey
  publication-title: Journal of Nuclear Medicine
  doi: 10.2967/jnumed.112.118877
– ident: CR8
– volume: 41
  start-page: 1402
  issue: 8
  year: 2017
  end-page: 1418
  ident: CR1
  article-title: Role of the dynorphin/kappa opioid receptor system in the motivational effects of ethanol
  publication-title: Alcoholism: Clinical and Experimental Research.
  doi: 10.1111/acer.13406
– volume: 22
  start-page: 1271
  issue: 10
  year: 2002
  end-page: 1281
  ident: CR3
  article-title: Strategies to improve Neuroreceptor parameter estimation by linear regression analysis
  publication-title: Journal of Cerebral Blood Flow & Metabolism.
  doi: 10.1097/01.WCB.0000038000.34930.4E
– volume: 86
  start-page: 864
  issue: 11
  year: 2019
  end-page: 871
  ident: CR2
  article-title: The kappa opioid receptor is associated with naltrexone-induced reduction of drinking and craving
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2019.05.021
– volume: 62
  start-page: 694
  issue: 6
  year: 2007
  end-page: 697
  ident: CR5
  article-title: Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2006.11.018
– volume: 43
  start-page: 2539
  issue: 13
  year: 2018
  ident: CR9
  article-title: PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age
  publication-title: Neuropsychopharmacology.
  doi: 10.1038/s41386-018-0199-1
– volume: 22
  start-page: 1271
  issue: 10
  year: 2002
  ident: 758_CR3
  publication-title: Journal of Cerebral Blood Flow & Metabolism.
  doi: 10.1097/01.WCB.0000038000.34930.4E
– volume: 62
  start-page: 694
  issue: 6
  year: 2007
  ident: 758_CR5
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2006.11.018
– volume: 160
  start-page: 19
  issue: 1
  year: 2002
  ident: 758_CR6
  publication-title: Psychopharmacology.
  doi: 10.1007/s002130100919
– volume: 54
  start-page: 1668
  issue: 9
  year: 2013
  ident: 758_CR4
  publication-title: Journal of Nuclear Medicine
  doi: 10.2967/jnumed.112.118877
– volume: 43
  start-page: 2539
  issue: 13
  year: 2018
  ident: 758_CR9
  publication-title: Neuropsychopharmacology.
  doi: 10.1038/s41386-018-0199-1
– ident: 758_CR8
– volume: 86
  start-page: 864
  issue: 11
  year: 2019
  ident: 758_CR2
  publication-title: Biological Psychiatry
  doi: 10.1016/j.biopsych.2019.05.021
– volume: 50
  start-page: 1027
  issue: 3
  year: 2010
  ident: 758_CR7
  publication-title: Neuroimage.
  doi: 10.1016/j.neuroimage.2009.12.119
– volume: 41
  start-page: 1402
  issue: 8
  year: 2017
  ident: 758_CR1
  publication-title: Alcoholism: Clinical and Experimental Research.
  doi: 10.1111/acer.13406
SSID ssj0054891
Score 2.3076982
Snippet Striatal kappa opioid receptor (KOR) availability in 48 subjects with Alcohol Use Disorder (AUD) was previously found to be associated with degree of drinking...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 367
SubjectTerms Alcohol Drinking
Alcohol use
Alcoholism - diagnostic imaging
Alcoholism - drug therapy
Biomedical and Life Sciences
Biomedicine
Brief Report
Clustering
Drinking
Drinking behavior
Humans
Image acquisition
Magnetic Resonance Imaging
Naltrexone
Naltrexone - therapeutic use
Neostriatum
Neuropsychology
Neuroradiology
Neurosciences
Opioid receptors (type kappa)
Positron emission
Positron-Emission Tomography - methods
Psychiatry
Receptors, Opioid, kappa
Reduction
Robustness
Sarin
Training
Variance analysis
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7aFEovJenTSVpU6K0VWFo9j0uaEFr6oGQhh4KxxzJdSLxl1wv9-RnJ9i7btIHejDV6eGakGWs0nwDekk2UJljk6BVy5WXJPdl93hhaCn3jha4T2ucXcz5THy_15ZAUthpPu48hybRSb5PdhCFvkGwMj3bOcXMfHuj4705aPJPTcf0lFzzdk0eeieBWazukyvy9jV1zdMvHvH1U8o94aTJDZ_vwePAf2bQX-AHcC-0TePh5iJA_hR8nV-uIfUCV2aJhn75-Z99OL9j8mtaNFVuFBPVNT_3JcRa3Ydl09oHN227B6jjhW-zYsj85S3T0lvrrluH3og3PYHZ2enFyzocbFDgqqzse01q9RkvCsN7JmmyPUZUsm1IiatF42eSYo6tz9ChUPdGuCt5UWPpcNUFOnsNeS82_BGYx906gi2FQZXPjrCNGYxnCRGClQwZiZGSBA7x4vOXiqtgCI0fmF8T8IjG_MBm829T51YNr3El9PMqnGCbaqpAuebQ0mgzebIppisS4R9mGxZporPGatE5REy96cW66m5hYZkUGbkfQG4IIv71b0s5_JhjumLIb0fsyeD_qxHZc__6Mw_8jP4JHMulr3Pg5hr1uuQ6vyA_qqtdJ7W8AN4H9DQ
  priority: 102
  providerName: Springer Nature
Title Clustering of KOR PET images separates people with AUD into distinct responses to naltrexone
URI https://link.springer.com/article/10.1007/s11682-023-00758-6
https://www.ncbi.nlm.nih.gov/pubmed/36695971
https://www.proquest.com/docview/2815071878
https://www.proquest.com/docview/2769591546
https://pubmed.ncbi.nlm.nih.gov/PMC11815977
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0BfFF_DZaywq-6WKyl_16krPetVispfTgBCEkkw0e1KTe5cA_35lNLsdZ7EsSdjcfOzO7M9mZ_Q1jb1EnSu0NCHApiNTJXDjU-6LSOBW6yiWqDGifZ_pkln6Zq3m_4Lbqwyo3c2KYqMsGaI38g7TBdLHGfrz-LShrFHlX-xQad9k-QZdRSJeZDz9caIyHjHlooyTCKGX6TTPd1rlEo22JGkuQ1rRC7yqmG9bmzaDJfzynQSFNH7IHvSXJxx3rH7E7vn7M7n3tfeVP2I-jqzWhIODNvKn46bcLfj655ItfOIOs-MoH0G-86mLIOS3I8vHsM1_UbcNLGvo1tHzZxdBiOyzF97VL_6ep_VM2m04uj05En0tBQGpUK2iDq1NgkC3GWVmiFtJpIfMqlwAqqZysYojBljE4SNJypGzhnS4gd3FaeTl6xvZqfPwLxg3EziZgySGamlgjS5DQkHs_SqBQPmLJhpAZ9EDjlO_iKttCJBPxMyR-Foif6Yi9G-657mA2bm19sOFP1g-5VbYVkIi9GapxsJAHJK99s8Y2RjuF8pfiI5537BxeN9JUZ5KI2R1GDw0IiHu3pl78DIDctHmXcPwi9n4jE9vv-n83Xt7ejVfsvgzySUs-B2yvXa79a7SA2uIwiDke7fT4kO2Pj7-fTvD8aXJ2foGlMzn-C7LWBTQ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIgEXxJuUAkaCE1gkTvw6IFS1XbZsWxDalXpAShPHESuVpN3NCvhT_EZmnGRXS0VvvUXxI_Z4PDPxeL4h5BXoRC6dssyaxLLE8IwZ0PuslCAKTWkiUXi0z2M5nCSfTsTJBvnTx8LgtcpeJnpBXdQWz8jfce1NF630h_MLhlmj0Lvap9Bo2WLkfv-EX7b5-4M9WN_XnA_2x7tD1mUVYDZRomEY6mmEVTBAZTQvQB7LJOdZmXFrRVQaXoY2tLoIrbFRUsRC587I3GYmTEqHQAcg8m8kcWxwR-nBx17yg_HvM_SBTRQxJYTqgnTaUL1Igi0LGpKhltZMrivCS9bt5Uua_3hqvQIc3CV3OsuV7rSsdo9suOo-uXnU-eYfkG-7ZwtEXYDGtC7p6PNX-mV_TKc_QGLN6dx5kHF4au-sUzwApjuTPTqtmpoWKGoq29BZe2cX6sFb-F4zc7_qyj0kk2uh8iOyWUH3TwhVNjQ6shodsIkKJbAAENpmzsWRzYULSNQTMrUdsDnm1zhLV5DMSPwUiJ964qcyIG-Wbc5bWI8ra2_365N2W3yerhgyIC-XxbA50eOSVa5eQB0ljQB-T6CLx-1yLj8XSyxTUUD02kIvKyDw93pJNf3uAcAxWBhxAwPytueJ1bj-P42tq6fxgtwajo8O08OD49FTcpt7XsXjpm2y2cwW7hlYX03-3LM8JafXvcf-AoIWPWs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemIU28IL4JDDASPIG12I2_HhCa1lUbhTGhVeoDUkgcR1QayWhTAf8afx13TtKqTOxtb1XtfJ3vy7673xHyEmyiUF475mziWGJFxizYfVYqUIW2tFwWAe3zRB1NkvdTOd0if_paGEyr7HViUNRF7fCMfE-Y4LoYbfbKLi3idDh6d_GDYQcpjLT27TRaFhn73z9h-7Z4ezyEtX4lxOjw7OCIdR0GmEu0bBiWfVrpNLystkYUoJtVkouszIRzkpdWlLGLnSliZx1PioE0ubcqd5mNk9Ij6AGo_xt6IDnKmJ6uNnuwEQjd-sA_4kxLqbuCnbZsjyvwa8FaMrTYhqlNo3jJ072csPlP1DYYw9FtcqvzYul-y3Z3yJav7pKdj12c_h75cnC-RAQGuJjWJR1_-kxPD8_o7DtorwVd-AA4Dr_a_HWKh8F0fzKks6qpaYFqp3INnbf5uzAP_oXnNXP_q678fTK5Fio_INsV3P4RodrF1nBnMBib6FgBOwChXeb9gLtc-ojwnpCp60DOsdfGebqGZ0bip0D8NBA_VRF5vbrmooX4uHL2br8-aSfui3TNnBF5sRoGQcXoS1b5eglztLISeD-BWzxsl3P1uIHCMc0jYjYWejUBQcA3R6rZtwAGjoXDiCEYkTc9T6zf6_-f8fjqz3hOdkC60g_HJ-Mn5KYIrIonT7tku5kv_VNwxJr8WeB4Sr5et4j9BUrBQZg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clustering+of+KOR+PET+images+separates+people+with+AUD+into+distinct+responses+to+naltrexone&rft.jtitle=Brain+imaging+and+behavior&rft.au=Hoye%2C+Jocelyn&rft.au=Key%2C+Jose&rft.au=de+Laat%2C+Bart&rft.au=Cosgrove%2C+Kelly+P.&rft.date=2023-06-01&rft.issn=1931-7557&rft.eissn=1931-7565&rft.volume=17&rft.issue=3&rft.spage=367&rft.epage=371&rft_id=info:doi/10.1007%2Fs11682-023-00758-6&rft_id=info%3Apmid%2F36695971&rft.externalDocID=PMC11815977
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-7557&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-7557&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-7557&client=summon